Search Results 801-810 of 12077 for Ibrance

1. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   The primary purpose of this study is to see how GLPG1690 works together with current standard treatment on lung function and IPF disease in general. The study ...

2. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer - Mayo Clinic

   About this study. This is a Phase Ib, open-label, randomized, multicenter, two-arm study designed to assess the safety, efficacy, and pharmacokinetics of ...

3. Gastroenterology and Hepatology - Clinical trials

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

4. Irinotecan (intravenous route) - Side effects & uses - Mayo Clinic

   This medicine is also given to patients with metastatic cancer of the colon or rectum who have received fluorouracil but disease has progressed or recurred.

5. Cancer survivorship clinics - Clinical trials - Mayo Clinic

   Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

6. Neurosciences Clinical Trials - Medical Professionals

   This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

7. A Study to Compare Whole Brain Radiotherapy and Memantine to Stereotactic Radiosurgery vs. Stereotactic Radiosurgery Alone to Treat Patients with Cancer That Has Spread to the Brain After Earlier Stereotactic Radiosurgery - Mayo Clinic

   Hippocampus avoidance during whole-brain radiation therapy decreases the amount of radiation that is delivered to the hippocampus, which is a brain structure ...

8. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   Inclusion Criteria: Diagnosis of Crohn's disease (CD) for at least 90 days, confirmed by endoscopy during the Screening Period.

9. Hematology - Clinical trials

   This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.

10. Drugs and Supplements that Start with S - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “S” to learn about drug side effects, proper use and ...